combretastatin has been researched along with nsc 600032 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glass, TE; Johnson, RK; Kingston, DG; Mattern, MR; Schwikkard, S; Sharp, JL; Zhou, BN | 1 |
| Anthoney, DA; Bibby, MC; Cooper, PA; Kirwan, IG; Lippert, JW; Loadman, PM; Pettit, GR; Shnyder, SD; Swaine, DJ | 1 |
2 other study(ies) available for combretastatin and nsc 600032
| Article | Year |
|---|---|
Bioactive compounds from Combretum erythrophyllum.
Topics: Antineoplastic Agents, Phytogenic; Bibenzyls; Carbohydrate Sequence; DNA Damage; DNA Repair; Drug Screening Assays, Antitumor; Glycosides; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Sequence Data; Plant Extracts; Plants, Medicinal; South Africa; Spectrophotometry, Ultraviolet; Stilbenes; Tumor Cells, Cultured; Wood | 2000 |
Comparative preclinical pharmacokinetic and metabolic studies of the combretastatin prodrugs combretastatin A4 phosphate and A1 phosphate.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Bibenzyls; Calibration; Cell Line, Tumor; Chromatography; Chromatography, High Pressure Liquid; Coloring Agents; Female; Humans; Inhibitory Concentration 50; Mass Spectrometry; Mice; Models, Chemical; Phosphorylation; Prodrugs; Stilbenes; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |